Religare Enterprises allotted 83.43 lakh equity shares at ₹235 each, raising ₹147.05 crore. This is part of a warrant conversion process approved by shareholders, increasing paid-up capital. The new shares are subject to a lock-in period.
Religare Enterprises has successfully allotted 83,43,263 equity shares at an issue price of ₹235 per share, including a premium of ₹225 over the ₹10 face value. This allotment has infused ₹147.05 crore into the company, representing 75% of the total consideration for the conversion of warrants. ## What just happened The company's Investment, Borrowing & Share Allotment (IB&SA) Committee approved the allotment on June 04, 2026. This move finalizes a warrant conversion process that was initially approved by shareholders in August 2025. The allottees include The Hindustan Times Ltd, Akhil Dhawan, Ashish Dhawan, VIC Enterprises Pvt Ltd, and JM Financial Credit Solutions Ltd. ## Why this matters This capital infusion strengthens Religare Enterprises' financial position by adding ₹147.05 crore to its liquidity. It also marks an increase in the company's paid-up equity capital from ₹332.89 crore to ₹341.23 crore, resulting in a total of 34,12,33,742 fully paid-up shares. The infusion is a result of executing a planned equity expansion strategy. ## The backstory The allotment stems from a warrant conversion process. Shareholders had approved this expansion in August 2025. The company had previously collected 25% of the total consideration during the initial warrant issuance, with the current allotment accounting for the remaining 75%. ## What changes now Religare Enterprises' paid-up equity capital has now increased. The total number of fully paid-up shares has risen to 34,12,33,742. Importantly, the newly issued shares are subject to lock-in requirements as per SEBI ICDR regulations, meaning they cannot be immediately traded by the allottees. ## Risks to watch Existing investors should be aware of potential earnings per share (EPS) dilution due to the increased number of shares. The utilization of the newly infused capital will be crucial for future performance. ## Context metrics (time-bound) * **Shares Allotted:** 83,43,263 Equity Shares * **Issue Price:** ₹235 per share * **Capital Infused:** ₹147.05 crore * **Pre-allotment Paid-up Equity Capital:** ₹332.89 crore * **Post-allotment Paid-up Equity Capital:** ₹341.23 crore * **Total Fully Paid-up Shares (Post-allotment):** 34,12,33,742 shares * **Allotment Approval Date:** June 04, 2026 * **Shareholder Approval for Warrant Conversion:** August 2025 ## What to track next Investors should closely monitor how Religare Enterprises deploys this additional capital and its impact on the company's profitability and financial metrics.
Get stock alerts instantly on WhatsApp
Quarterly results, bulk deals, concall updates and major announcements delivered in real time.
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.
